AGP Executive Report
Last update: 7 hours agoHemp Policy Fight: Congress is debating a nationwide ban on hemp-infused products, with Lancaster County businesses and farmers bracing for what it could mean for THC edibles and oils; Montana hemp processors also praised a U.S. Senate delay of a hemp ban, buying time for a longer-term fix. Medical Cannabis Research: New clinical reporting points to oral CBD helping with post-surgery ocular pain as effectively as opioids, while separate studies link medical cannabis to sustained improvements for endometriosis patients and reduced opioid use. Public Health Watch: The CDC is warning of a spike in emergency room visits tied to cannabis hyperemesis syndrome after a new diagnosis code, and UK reporting highlights fatal crashes involving cannabis edibles—fueling calls for tighter safety and education. Industry/Markets: Avicanna posted Q2 2026 results, highlighting growth in proprietary product sales and progress toward profitability. Legal/Enforcement: A drug dealer facing sentencing after a cannabis supply case and multiple international drug seizures keep the spotlight on enforcement pressure around cannabis and other drugs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
